Materials • Major Chemicals
$13.62 ▼ -0.10
(-0.73%)
MKT CAP: $954.7M • VOL: 959.1K
52W L $9 52W H $20
GPRE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $189.0M | $163.0M | $136.3M |
| YoY Revenue Growth % | +16.0% | +19.6% | — |
| Gross Profit | $136.9M | $130.4M | — |
| Gross Margin % | 72.5% | 80.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$67.2M | -$47.5M | -$61.6M |
| Operating Margin % | -35.6% | -29.1% | -45.2% |
| Net Income (GAAP) | -$121.3M | -$82.5M | -$93.4M |
| EBITDA (Normalized) | -$37.5M | $28.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $110.9M | -$30.0M | $56.3M |
| Capital Expenditures (CapEx) | $37.2M | $95.1M | — |
| Free Cash Flow (FCF) | $73.7M | -$125.0M | $56.3M |
| FCF Margin % | 39.0% | -76.7% | 41.3% |
| Return on Invested Capital (ROIC %) | -5.6% | -3.3% | — |
| Cash & Short-Term Equivalents | $182.3M | $173.0M | — |
| Total Debt (Short + Long Term) | $362.0M | $432.5M | — |
| Total Stockholders' Equity | $766.2M | $865.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR GPRE.